Refreshing results…
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma
UploadSevere impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma
UploadMissing publications? Search for publications with a matching author name.